Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.

K A Gelmon; J Latreille; A Tolcher; L Génier; B Fisher; D Forand; S D'Aloisio; L Vernillet; L Daigneault; A Lebecq

doi:10.1200/JCO.2000.18.24.4098

Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.

NobleID: NI2P22W56R57S66
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/4FBC674F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4FBC674F.svg?ark=w1%2F20260515%2F4FBC674F&value=id)](https://nobleid.org/work/w1/20260515/4FBC674F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.

NobleID: NI2P22W56R57S66
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/4FBC674F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4FBC674F.svg?ark=w1%2F20260515%2F4FBC674F&value=id)](https://nobleid.org/work/w1/20260515/4FBC674F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work